Nextcure Stock Market Capitalization
| NXTC Stock | USD 0.61 0.04 7.02% |
NextCure fundamentals help investors to digest information that contributes to NextCure's financial success or failures. It also enables traders to predict the movement of NextCure Stock. The fundamental analysis module provides a way to measure NextCure's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NextCure stock.
NextCure |
NextCure Company Market Capitalization Analysis
NextCure's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current NextCure Market Capitalization | 15.96 M |
Most of NextCure's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NextCure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of NextCure is about 15.96 M. This is 99.88% lower than that of the Biotechnology sector and 99.66% lower than that of the Health Care industry. The market capitalization for all United States stocks is 99.92% higher than that of the company.
NextCure Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NextCure's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NextCure could also be used in its relative valuation, which is a method of valuing NextCure by comparing valuation metrics of similar companies.NextCure is currently under evaluation in market capitalization category among its peers.
NextCure Fundamentals
| Return On Equity | -0.62 | ||||
| Return On Asset | -0.34 | ||||
| Current Valuation | (46.71 M) | ||||
| Shares Outstanding | 28.01 M | ||||
| Shares Owned By Insiders | 7.01 % | ||||
| Shares Owned By Institutions | 52.48 % | ||||
| Number Of Shares Shorted | 59.22 K | ||||
| Price To Earning | (25.44) X | ||||
| Price To Book | 0.24 X | ||||
| Price To Sales | 9.52 X | ||||
| Gross Profit | (54.2 M) | ||||
| EBITDA | (54.34 M) | ||||
| Net Income | (55.65 M) | ||||
| Cash And Equivalents | 185.49 M | ||||
| Cash Per Share | 6.68 X | ||||
| Total Debt | 5.15 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 33.87 X | ||||
| Book Value Per Share | 2.34 X | ||||
| Cash Flow From Operations | (40.8 M) | ||||
| Short Ratio | 1.31 X | ||||
| Earnings Per Share | (1.99) X | ||||
| Price To Earnings To Growth | 0.03 X | ||||
| Target Price | 3.0 | ||||
| Number Of Employees | 43 | ||||
| Beta | 0.71 | ||||
| Market Capitalization | 15.96 M | ||||
| Total Asset | 80.86 M | ||||
| Retained Earnings | (380.14 M) | ||||
| Working Capital | 62.23 M | ||||
| Current Asset | 46.99 M | ||||
| Current Liabilities | 5.53 M | ||||
| Net Asset | 80.86 M |
About NextCure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NextCure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NextCure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NextCure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out NextCure Piotroski F Score and NextCure Altman Z Score analysis. For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NextCure. If investors know NextCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NextCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NextCure is measured differently than its book value, which is the value of NextCure that is recorded on the company's balance sheet. Investors also form their own opinion of NextCure's value that differs from its market value or its book value, called intrinsic value, which is NextCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NextCure's market value can be influenced by many factors that don't directly affect NextCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NextCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if NextCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NextCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.